| Literature DB >> 7889566 |
U Klingmüller1, U Lorenz, L C Cantley, B G Neel, H F Lodish.
Abstract
The binding of erythropoietin (EPO) to its receptor (EPO-R) activates the protein tyrosine kinase JAK2. The mechanism of JAK2 inactivation has been unclear. We show that the hematopoietic protein tyrosine phosphatase SH-PTP1 (also called HCP and PTP1C) associates via its SH2 domains with the tyrosine-phosphorylated EPO-R. In vitro binding studies suggest that Y429 in the cytoplasmic domain of the EPO-R is the binding site for SH-PTP1. Mutant EPO-Rs lacking Y429 are unable to bind SH-PTP1; cells expressing such mutants are hypersensitive to EPO and display prolonged EPO-induced autophosphorylation of JAK2. Our results suggest that activation of SH-PTP1 by binding to the EPO-R plays a major role in terminating proliferative signals.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7889566 DOI: 10.1016/0092-8674(95)90351-8
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582